Movement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Stock Retreats as Market Remains Divided over ProBio Spin-Off Impact

Market Focus

Yesterday

On September 9, GENSCRIPT BIO declined 3.29% in regular trading, trading at 33.84 HKD/share, with turnover of approximately 67.16 million HKD. The stock continued to show volatile trading following the announcement of its proposed spin-off of ProBio Technology.

The company announced on September 4 that it proposed to spin off its indirect non-wholly owned subsidiary ProBio Technology Limited for a separate listing on the HKEX main board. The Listing Committee confirmed on August 14 that the company could proceed with the proposed spin-off. On the day of the announcement, the stock plunged nearly 13%, then rebounded over 8% on September 8 as the market digested the news. The renewed pullback reflects ongoing market divergence over the spin-off's implications. Analysts note that the spin-off may help alleviate approximately USD 473 million in redemption pressure stemming from ProBio's preferred share agreements, and that GENSCRIPT BIO will retain its controlling interest with ProBio's financials remaining consolidated.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/news/1134283229"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134283229\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1134283229?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-09 09:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134283229","market":"hk","top_or_hot":-1,"title":"Movement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Stock Retreats as Market Remains Divided over ProBio Spin-Off Impact","media":"Market Focus","content":"<p><p>On September 9, GENSCRIPT BIO declined 3.29% in regular trading, trading at 33.84 HKD/share, with turnover of approximately 67.16 million HKD. The stock continued to show volatile trading following the announcement of its proposed spin-off of ProBio Technology.</p><p>The company announced on September 4 that it proposed to spin off its indirect non-wholly owned subsidiary ProBio Technology Limited for a separate listing on the HKEX main board. The Listing Committee confirmed on August 14 that the company could proceed with the proposed spin-off. On the day of the announcement, the stock plunged nearly 13%, then rebounded over 8% on September 8 as the market digested the news. The renewed pullback reflects ongoing market divergence over the spin-off's implications. Analysts note that the spin-off may help alleviate approximately USD 473 million in redemption pressure stemming from ProBio's preferred share agreements, and that GENSCRIPT BIO will retain its controlling interest with ProBio's financials remaining consolidated.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Stock Retreats as Market Remains Divided over ProBio Spin-Off Impact</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GENSCRIPT BIO Falls 3.29% in Regular Trading, Stock Retreats as Market Remains Divided over ProBio Spin-Off Impact\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-09 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 9, GENSCRIPT BIO declined 3.29% in regular trading, trading at 33.84 HKD/share, with turnover of approximately 67.16 million HKD. The stock continued to show volatile trading following the announcement of its proposed spin-off of ProBio Technology.</p><p>The company announced on September 4 that it proposed to spin off its indirect non-wholly owned subsidiary ProBio Technology Limited for a separate listing on the HKEX main board. The Listing Committee confirmed on August 14 that the company could proceed with the proposed spin-off. On the day of the announcement, the stock plunged nearly 13%, then rebounded over 8% on September 8 as the market digested the news. The renewed pullback reflects ongoing market divergence over the spin-off's implications. Analysts note that the spin-off may help alleviate approximately USD 473 million in redemption pressure stemming from ProBio's preferred share agreements, and that GENSCRIPT BIO will retain its controlling interest with ProBio's financials remaining consolidated.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1134283229","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134283229","pubTimestamp":1788917868,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 9, GENSCRIPT BIO declined 3.29% in regular trading, trading at 33.84 HKD/share, with turnover of approximately 67.16 million HKD. The stock continued to show volatile trading following...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"走势警报|金斯瑞生物在常规交易中下跌 3.29%，由于市场对 ProBio 分拆的影响仍存在分歧，股价回落","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On September 9, GENSCRIPT BIO declined 3.29% in regular trading, trading at 33.84 HKD/share, with turnover of approximately 67.16 million HKD. The stock continued to show volatile trading following the announcement of its proposed spin-off of ProBio Technology.The company announced on September 4 that it proposed to spin off its indirect non-wholly owned subsidiary ProBio Technology Limited for a separate listing on the HKEX main board. The Listing Committee confirmed on August 14 that the company could proceed with the proposed spin-off. On the day of the announcement, the stock plunged nearly 13%, then rebounded over 8% on September 8 as the market digested the news. The renewed pullback reflects ongoing market divergence over the spin-off's implications. Analysts note that the spin-off may help alleviate approximately USD 473 million in redemption pressure stemming from ProBio's preferred share agreements, and that GENSCRIPT BIO will retain its controlling interest with ProBio's financials remaining consolidated.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}